Optimal cutoff value of high-density lipoprotein cholesterol for predicting coronary artery disease in Taiwanese population

Nutrition Research

Volumn 30, Issue 1, 2010, Pages 21-26

  Huang, Yi Chia ^a   Ho, Chien Chang ^b   Lin, Ping Ting ^a   Lee, Bor Jen ^c   Lai, Cheng Hsiu ^b   Liaw, Yung Po ^a,d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b UNIVERSITY OF TAIPEI   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Coronary artery disease; High density lipoprotein cholesterol; Human; Low density lipoprotein cholesterol; Optimal cutoff value; Receiver operating characteristic curve

Indexed keywords

C REACTIVE PROTEIN; CREATININE; CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PYRIDOXAL 5 PHOSPHATE; TRIACYLGLYCEROL;

AGE; AGED; ARTICLE; BLOOD CHEMISTRY; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; HEART CATHETERIZATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; TAIWAN; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; CORONARY STENOSIS; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; REFERENCE VALUES; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TAIWAN;

EID: 74549161524     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2009.11.003     Document Type: Article

References (29)

1. Miller M., Mead L.A., Kwiterovich P.O., and Pearson T.A. Dyslipidemias with desirable plasma total cholesterol concentrations and angiographically demonstrated coronary artery disease. Am J Cardiol 65 (1990) 1-5
2. Kannel W.B., Castelli W.P., Gordon T., and McNamara P.M. Serum cholesterol, lipoproteins and risk of coronary heart diseases. The Framingham study. Ann Intern Med 74 (1971) 1-12
3. Wilson P.W., Abbott R.D., and Castelli W.P. High density lipoprotein cholesterol and mortality. The Framingham Heart Study. Arteriosclerosis 8 (1988) 737-741
4. National Cholesterol Education Program Adult Treatment Panel III. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
5. Rudel L.L., and Kesainiemi A. Low-density lipoprotein particle composition: what is the contribution to atherogenicity?. Curr Opin Lipidol 11 (2000) 227-228
6. Burman A., Jain K., Gulati R., Chopra V., Agarwal D.P., and Vasisht S. Lipoprotein(a) as a marker of coronary artery disease and its association with dietary fat. J Assoc Physicians India 52 (2004) 99-102
7. Manninen V., Elo M.O., Frick M.H., Haapa K., Heinonen O.P., Heinsalmi P., et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 260 (1988) 641-651
8. Manninen V., Tenkanen L., Koskinen P., Huttunen J.K., Manttari M., Heinonen O.P., et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation 85 (1992) 37-45
9. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., and Dawber T.R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62 (1977) 707-714
10. Robins S.J., Collins D., Wittes J.T., Papademetriou V., Deedwania P.C., Schaefer E.J., et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA 285 (2001) 1585-1591
11. Von Eckardstein A., Nofer J.R., and Assmann G. High density lipoproteins and atherosclerosis: role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 21 (2001) 13-27
12. Barr D.P., Russ E.M., and Eder H.A. Protein-lipid relationship in human plasma. II. In atherosclerosis and related conditions. Am J Med 11 (1951) 480-493
13. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel III. JAMA 285 (2001) 2486-2497
14. Allison M.A., and Wright C.M. A comparison of HDL and LDL cholesterol for prevalent coronary calcification. Int J Cardiol 95 (2004) 55-60
15. Swets J.A. Measuring the accuracy of diagnostic systems. Science 240 (1988) 1285-1293
16. Araki A., and Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422 (1987) 43-52
17. Bates C.J., Pentieva K.D., Matthews N., and Macdonald A. A simple sensitive and reproducible assay for pyridoxal 5′-phosphate and 4-pyridoxic acid in human plasma. Chin Chim Acta 280 (1999) 101-111
18. David W.H., and Stanley L. Applied logistic regression. 2nd ed. (2000), John Wiley & Sons, Inc., New York 31-46
19. Plutzky J. Emerging concepts in metabolic abnormalities associated with coronary artery disease. Curr Opin Cardiol 15 (2000) 416-421
20. Gordon D.J., Probstfield J.L., Garrison R.J., Neaton J.D., Castelli W.P., Knoke J.D., et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 79 (1989) 8-15
21. Satoh H., Nishino T., Tomita K., Saijo Y., Kishi R., and Tsutsui H. Risk factors and the incidence of coronary artery disease in young middle-aged Japanese men: results from a 10-year cohort study. Intern Med 45 (2006) 235-239
22. Stamler J., Wentworth D., and Neaton J.D. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the multiple risk factor intervention trial (MRFIT). JAMA 256 (1986) 2823-2828
23. Assmann G., and Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidences of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster Study. Am J Cardiol 70 (1992) 733-737
24. Zeljkovic A., Spasojevic-Kalimanovska V., Vekic J., Jelic-Ivanovic Z., Topic A., Bogavac-Stanojevic N., et al. Does simultaneous determination of LDL and HDL particle size improve prediction of coronary artery disease risk?. Clin Exp Med 8 (2008) 109-116
25. Rasouli M., Kiasari A.M., and Mokhber L.V. The ratio of apoB/apoA1, apoB and. lipoprotein(a) are the best predictors of stable coronary artery disease. Clin Chem Med 44 (2006) 1015-1021
26. Sato I., Taniguchi T., Ishikawa Y., Kusuki M., Hayashi F., Mukai M., et al. The lipoprotein fraction between VLDL and LDL detected by biphasic agarose gel electrophoresis reflects serum remnant lipoprotein and Lp(a) concentrations. J Atheroscler Thromb 13 (2006) 55-61
27. Bogavac-Stanojević N., Jelić-Ivanović Z., Spasojević-Kalimanovska V., Spasić S., and Kalimanovska-Ostrić D. Lipid and inflammatory markers for the prediction of coronary artery disease: a multi-marker approach. Clin Biochem 40 (2007) 1000-1006
28. Genest J., McNamara J.R., Ordovas J.M., Jenner J.L., Silberman S.R., Anderson K.M., et al. Lipoprotein cholesterol, apolipoprotein A-I and B and lipoprotein (a) abnormalities in men with premature coronary artery disease. J Am Coll Cardiol 19 (1992) 792-802
29. Hertzer N.R., Beven E.G., Young J.R., O'Hara P.J., Ruschhaupt W.F., Graor R.A., et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 199 (1984) 223-233